Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...
In the world of biomechanics and medicine, there are challenges in the designing microrobots that are effective in drug ...
Medicare is launching a new pilot program that will require prior approval for 17 health services using artificial ...